Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(+)-amphetamine
(+)-α-methylphenethylamine
(S)-amphetamine
Dexanfetamina
Dextroamphetamine saccharate
(S)-(+)-β-phenylisopropylamine
(S)-(+)-amphetamine
Dexamphetamine
Dexamfetamina
Dexamfetamine
(S)-1-phenyl-2-aminopropane
(S)-1-phenyl-2-propylamine
Dextroamphetamine adipate
d-amphetamine
(+)-α-methylphenylethylamine
(+)-(S)-amphetamine
(αS)-α-methylbenzeneethanamine
Dexamfetaminum
Dextroamphetamine
Dextroamphetamine sulfate
(S)-α-methylbenzeneethanamine
Desamfetamina
Brand Names
Adderall XR
Dexedrine Spansule
Dexedrine Spansule Src 10mg
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682